anifrolumab - Medications

Browse 1 medications containing anifrolumab. Open a product record to review formulation details, related brands, manufacturers, and label-backed information.

SAPHNELO ANIFROLUMAB FNIA
ASTRAZENECA PHARMACEUTICALS LP FDA Rx Only

Anifrolumab-fnia is a type I interferon (IFN) receptor antagonist, immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that is produced in mouse myeloma cells (NS0) by recombinant DNA technology. The molecular weight is approximately 148 kDa. SAPHNELO (anifrolumab-fnia) injection is a sterile, preservative‑free, clear to opalescent, colorless to slightly yellow, solution for intravenous use. SAPHNELO contains anifrolumab-fnia at a concentration of 150 mg/mL in a single-dose vial. Each vial contains 300 mg (150 mg/mL) of anifrolumab-fnia, L-histidine (3 mg), L-histidine hydrochloride monohydrate (6 mg), L-lysine hydrochloride (18 mg), polysorbate 80 (1 mg), trehalose dihydrate (98 mg), and Water for Injection, USP. The pH is 5.9.

About anifrolumab

This collection groups medications in our database that include anifrolumab. It currently includes 1 matching listing.

What You Can Review

Use this page to find products that share the same indexed ingredient name, then open drug detail pages for dosage, labeling, and related navigation.

Safety Information

Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. The information provided on this page is for educational purposes only and does not constitute medical advice.

Medical Tools & Resources

← Back to search